Hepato p ancreaticobiliary R esection Arginine I mmuno m odulation (PRIMe) trial: protocol for a randomised phase II trial of the impact of perioperative immunomodulation on immune function following resection for hepatopancreaticobiliary malignancy.
Ramy BehmanRebecca C AuerLev BubisGrace XuNatalie G CoburnGuillaume MartelJulie HalletFady BalaaCalvin LawKimberly A BertensJad Abou KhalilPaul Jack KaranicolasPublished in: BMJ open (2024)
ClinicalTrials.gov identifier: NCT04549662.